Navigation Links
International Isotopes Inc. Announces a Shareholder Conference Call for February 7, 2011
Date:1/31/2011

IDAHO FALLS, Idaho, Jan. 31, 2011 /PRNewswire/ -- International Isotopes Inc. (OTC Bulletin Board: INIS), a leading manufacturer of nuclear medicine products, announces a conference call to discuss progress during the fourth quarter of 2010 on the Company's planned uranium de-conversion and fluorine extraction processing facility.

What: International Isotopes Inc. Depleted Uranium Project Update Conference CallWhen: Monday, February 7, 2011 - 10:00AM Central TimeHow:  Live via phone by dialing 800-624-7038. Code: INIS Uranium Project. Participants to the conference call should call in at least 5 minutes prior to the start time. For those who can not attend the call, an audio replay be archived on the Company's web site www.intisoid.com on Tuesday, February 8, 2011.This announcement follows the December 15, 2010 news release of the Company regarding the formation of a new joint venture business with RadQual LLC, and acquisition of the assets of Technology Imaging Services Inc.

Steve T. Laflin, President and CEO will lead the call to discuss the Company's progress on its planned depleted uranium processing and fluorine extraction processing facility during the fourth quarter of 2010 and outline some of the significant milestones the Company plans to accomplish on this project during 2011.

About International Isotopes Inc.International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources.  The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients. The Company is in the licensing and design phase of its planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility located near Hobbs, New Mexico.

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to its planned depleted uranium processing and fluorine extraction facility.  Information contained in such forward-looking statements is based on current expectations and is subject to change.  These statements involve a number of risks, uncertainties, and other factors that could cause actual results, performance or achievements of International Isotopes, Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.  Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes, Inc.'s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-K for the year ending December 31, 2009.  Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.FOR MORE INFORMATION CONTACT:Jim DrewitzCreative Options CommunicationsInvestor and Public Relationsjim@jdcreativeoptions.comPhone:  830-669-2466For more information, please visit the Company web site:  www.intisoid.com


'/>"/>

SOURCE International Isotopes Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
2. 4th International Conference on Electrophoretic Deposition
3. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
4. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
5. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
6. Web of international collaboration boosts worldwide nanotechnology research
7. ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program
8. Egon Zehnder International Names Todd Hutchings to Lead Life Sciences Practice Group
9. Nu Skin Scientists Present ageLOC Research at International Conference on Mitochondria
10. Medizone International Secures $10,000,000 Funding Commitment
11. PRA International Expert to Speak at China Drug Safety Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... LEAWOOD, Kan. , Feb. 22, 2017  Aratana Therapeutics, ... licensing, development and commercialization of innovative biopharmaceutical products for companion ... 14, 2017 at 8:30 a.m. ET to discuss financial results ... 2016. Interested participants and investors may access ... dial-in: ...
(Date:2/22/2017)... Fort Washington, PA (PRWEB) , ... ... ... The Omnia-Prova Education Collaborative (TOPEC), the leading medical education provider of ... Accreditation with Commendation by the Accreditation Council for Continuing Medical Education (ACCME). ...
(Date:2/22/2017)... , Feb. 22, 2017 Origin (Origin Agritech, LLC, a ... and seed provider, and Arcadia (Arcadia Biosciences, ... develops and commercializes agricultural productivity traits and nutritional products, today announced ... biotechnology product developed in China to ... trials. ...
(Date:2/22/2017)... SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., ... UTHR ) today announced its financial results ... 2016. "Our annual 2016 financial results ... billion and earnings exceeded $700 million," said Martine ... Officer. "These financial results strengthen our ability to ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)... Feb. 2, 2017  EyeLock LLC, a market leader ... white paper " What You Should Know About Biometrics ... ensuring user authenticity is a growing concern. In traditional ... users. However, traditional authentication schemes such as username/password suffer ... Biometric authentication offers an elegant solution to the problem ...
Breaking Biology News(10 mins):